Verde Bio Holdings Inc (APHD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access APHD Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Verde Bio Holdings Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jan 31 2024)
(Oct 31 2023) (Jul 31 2023) (Apr 30 2023) (Jan 31 2023)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Accounts receivable0.05
Accounts Receivable, Related Parties, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.04
Total Current Assets0.10
Equipment/Property/Plant Net1.22
Other Assets, Noncurrent0.00
Total Assets1.88
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.22
Convertible Debt, Current LO0.07
Other Liabilities, Current0.00
Total Current Liabilities0.29
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.60
Stockholders' Equity
Common Stock Value1.93
Additional Paid In Capital Common Stock16.36
Retained Earnings / Accumulated Deficit-18.17
Defined Benefit Plan and Other1.23
Other Equity0.00
Common Stockholder's Equity-0.05
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.17
Total Stockholder's Equity0.12
Liabilities & Stockholder's Equity1.88
4 historic quarters locked

Sign in to unlock the full Verde Bio Holdings Inc balance sheet history.

About Verde Bio Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-24-025549

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.